Kexing Biopharm (688136.SH) grants 3.786 million restricted stocks at a price of 12 yuan per share.

Kexing Biopharm (688136.SH) announced that the restricted stocks of Sinovac Biotech Limited will be issued in 2024. ...

According to the "2024 Restricted Stock Incentive Plan (Draft)" of Sinovac Biotech Limited in the announcement of Kexing Biopharm (688136.SH), the conditions for granting the restricted stocks in 2024 have been met. The company has determined June 14, 2024 as the grant date, and will grant 3.786 million restricted stocks at a grant price of RMB 12/share to 147 qualified incentive objects.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

科兴制药(688136.SH)以12元/股的价格授予378.6万股限制性股票

Kexing Biopharm (688136.SH) grants 3.786 million restricted stocks at a price of 12 yuan per share.

Risk Disclaimer

Statement